首页 › 基金 › HEIGHTS CAPITAL MANAGEMENT, INC › CABA
HEIGHTS CAPITAL MANAGEMENT, INC 对 CABA 的持仓历史
CABALETTA BIO INC · 医疗保健
HEIGHTS CAPITAL MANAGEMENT, INC 在 Q3 2026 的 13F 申报中披露持有 CABA(CABALETTA BIO INC)2,500,000 股,市值约 US$4.8M,约占其申报组合的 1.19%,在其申报持仓中市值排名第 18 位。 HEIGHTS CAPITAL MANAGEMENT, INC 最近 6 个申报季度中有 4 个季度披露了 CABA 持仓,最早可追溯至 Q2 2025。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
HEIGHTS CAPITAL MANAGEMENT, INC 对 CABA 的持仓演变
HEIGHTS CAPITAL MANAGEMENT, INC 于 Q2 2025 首次披露 CABA 持仓:3,144,106 股(约 US$4.8M)。 该持仓在 Q3 2025 达到峰值 2,084,202 股,市值约 US$4.9M。 在 4 次申报中,HEIGHTS CAPITAL MANAGEMENT, INC 1 次增持、1 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 2,500,000 股、市值约 US$4.8M,环比增持 1,744,374 股。。 持仓曾出现大幅变动:Q3 2025 减持约 34% (随后一个季度股价下跌 6%)、Q3 2026 增持约 231% (随后一个季度股价下跌 42%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q2 2025 | 3.14M | $4.78M | 新进 |
| Q3 2025 | 2.08M | $4.88M | 减持 |
| Q2 2026 | 755.63K | $2.35M | 新进 |
| Q3 2026 | 2.50M | $4.80M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 CABA 与 13F 数据
CABA(CABALETTA BIO INC)属于医疗保健行业。我们追踪的基金中还有 29 只申报持有 CABA,申报仓位最大的包括:Bain Capital Life Sciences Investors, LLC (US$40.7M), Opaleye Management Inc. (US$12.0M), Cormorant Asset Management, LP (US$8.6M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 CABA 的基金
- Bain Capital Life Sciences Investors, LLC 21.21M 股 · $40.72M · Q3 2026
- Opaleye Management Inc. 3.86M 股 · $12.02M · Q2 2026
- Cormorant Asset Management, LP 4.50M 股 · $8.64M · Q3 2026
- Propel Bio Management, LLC 2.05M 股 · $3.93M · Q3 2026
- Diametric Capital, LP 1.87M 股 · $3.60M · Q3 2026
更多关于 HEIGHTS CAPITAL MANAGEMENT, INC
常见问题
How long has HEIGHTS CAPITAL MANAGEMENT, INC held CABA?
HEIGHTS CAPITAL MANAGEMENT, INC has disclosed CABA holdings in 4 of the last 6 reported quarters, going back to Q2 2025.
What is HEIGHTS CAPITAL MANAGEMENT, INC's current position in CABA?
As of Q3 2026, HEIGHTS CAPITAL MANAGEMENT, INC holds 2.50M shares of CABA (CABALETTA BIO INC), valued at $4.80M, representing 1.19% of its reported portfolio and ranking #18.
Has HEIGHTS CAPITAL MANAGEMENT, INC been buying or selling CABA?
In the latest 13F filing (Q3 2026), HEIGHTS CAPITAL MANAGEMENT, INC increased its position in CABA. The position peaked in Q3 2025 at 2.08M shares.
Which other funds hold CABA?
Other major institutional holders of CABA include Bain Capital Life Sciences Investors, LLC, Opaleye Management Inc., Cormorant Asset Management, LP, among 29 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.